Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 6 Leukemia, Myeloid, Acute 3 Carcinoma, Non-Small-Cell Lung 3 Neoplasms 2 Kidney Neoplasms 2 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Skin Neoplasms 1 Recurrence 1 Radiation Injuries 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1 Pleural Effusion, Malignant 1 Platinum Resistant Ovarian Cancer 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Myelodysplastic Syndromes 1 Mycosis Fungoides 1 Melanoma 1 Lymphopenia 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, B-Cell, Marginal Zone 1 Lung Neoplasms 1 Hot Flashes 1 Hodgkin Disease 1 Gangliosidosis, GM1 1 Gangliosidoses 1 Fatigue 1

Interventions

efineptakin alfa 1 Sodium Chloride 1 Interleukin-7 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Lymphopenia × Sodium Chloride × Clear all

NCT04426201 2024-04-11

ILIAD-7-US-O

Revimmune

Phase 2 Terminated

COVID-19, Lymphopenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡